| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/26/2009 | US20090054492 such as 3-iodo-N-{2-[1-methyl-4-(trifluoromethyl)-1H-pyrazol-3-yl]ethyl}thiophene-2-carboxamide for use as fungicide, for treating plants; for phytopathogenic fungi of crops |
| 02/26/2009 | US20090054489 Multimediator Dopamine Transport Inhibitors, and Uses Related Thereto |
| 02/26/2009 | US20090054487 Pharmaceutical composition for increasing the mitochondrial genesis |
| 02/26/2009 | US20090054475 treatment of Type II diabetes and other diseases associated with poor glycemic control |
| 02/26/2009 | US20090054474 2-[N-[3-(N-cyclopentylmethyl-N-ethyl)amino-6-methoxypyridin-2-yl]methyl-N-(3-trifluoromethylbenzyl)]amino-5-(2-methylthioethoxy)pyrimidine, having cholesterol ester transfer protein inhibitory activity, used for treating hyperlipidemia and arteriosclerotic diseases |
| 02/26/2009 | US20090054466 Leukotriene B4 Inhibitors |
| 02/26/2009 | US20090054465 N-hydroxyacrylamide compounds |
| 02/26/2009 | US20090054464 Hdac inhibitor |
| 02/26/2009 | US20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054460 Piperazine derivatives and methods of use |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054456 Benzylpiperazine derivatives and their medical use |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054447 2,3 Substituted Pyrazine Sulfonamides as Inhibitors of CRTH2 |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054436 anticarcinogenic compounds; ; N-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenyl)-2-bromoisonicotinamide, trifluoroacetic acid salt; inhibit the protein tyrosine kinase activity of growth factor receptors like Hepatocyte growth factor |
| 02/26/2009 | US20090054435 Phenoxyalkanoic Acid Compound |
| 02/26/2009 | US20090054434 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| 02/26/2009 | US20090054432 2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors |
| 02/26/2009 | US20090054431 Novel heterocycle compounds |
| 02/26/2009 | US20090054429 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 02/26/2009 | US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054411 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors |
| 02/26/2009 | US20090054407 such as 4-Methanesulfonyloxy-5-methoxy-7-[1H-5-(methylaminomethyl)indol-2-yl]isoindolinone, having an antitumor activity |
| 02/26/2009 | US20090054405 PI3 kinase modulators and methods of use |
| 02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054396 Substituted thiophenes and uses thereof |
| 02/26/2009 | US20090054395 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 02/26/2009 | US20090054352 Benzene derivative or salt thereof |
| 02/26/2009 | CA2697325A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | CA2697284A1 Therapeutic quinoline and naphthalene derivatives |
| 02/26/2009 | CA2697100A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2697081A1 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | CA2696429A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity |
| 02/26/2009 | CA2696197A1 Pyridoneamide derivatives as focal adhesion kinase (fak) inhibitors and their use for the treatment of cancer |
| 02/26/2009 | CA2691450A1 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 02/25/2009 | EP2027120A2 Mglur5 modulators i |
| 02/25/2009 | EP2027112A2 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
| 02/25/2009 | EP2027111A2 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| 02/25/2009 | EP2027110A2 Mglur5 modulators iii |
| 02/25/2009 | EP2027109A1 4- (2, 6-dichloro-benzoylamino) -1h-pyrazole-s-carboxylic acid (1-methanesulph0nyl-piperidin-4-yl) -amide for the treatment of cancer |
| 02/25/2009 | EP2027108A1 Histamine receptor antagonists comprising an azepin core |
| 02/25/2009 | EP2027107A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 02/25/2009 | EP2027106A2 Cgrp receptor antagonists |
| 02/25/2009 | EP2027098A1 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro (4.5)dec-3-en-2-one derivatives and their use as glycine transporter inhibitors |
| 02/25/2009 | EP2027096A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors |
| 02/25/2009 | EP2027094A2 Method of preparing 4-halogenated quinoline intermediates |
| 02/25/2009 | EP2027091A1 New pharmaceutical compounds |
| 02/25/2009 | EP2027090A2 Mglur5 modulators ii |
| 02/25/2009 | EP2027088A2 Compounds for the treatment of spinal muscular atrophy and other uses |
| 02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
| 02/25/2009 | EP2027086A2 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 02/25/2009 | EP1904476B1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 02/25/2009 | EP1885695B1 Indoline compounds |
| 02/25/2009 | EP1878732B1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 02/25/2009 | EP1716126B1 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 02/25/2009 | EP1578726B1 Tetrahydroquinoline derivatives |
| 02/25/2009 | EP1506188B1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
| 02/25/2009 | EP1015445B1 Antimicrobial quinolones, their compositions and uses |
| 02/25/2009 | CN101374828A Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 02/25/2009 | CN101374820A Piperazine compounds with a herbicidal action |
| 02/25/2009 | CN101374817A Trisubstituted amine compound as inhibitors of cholesteryl ester transfer protein cetp |
| 02/25/2009 | CN101374814A Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/25/2009 | CN101374811A Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations |
| 02/25/2009 | CN101374808A Indole sulfonamide modulators of progesterone receptors |
| 02/25/2009 | CN101374517A Use of 2-imidazoles for the treatment of CNS disorders |
| 02/25/2009 | CN101374516A Use of substituted 2-imidazole of imidazoline derivatives |
| 02/25/2009 | CN101372484A Asymmetric synthesis method of chiral benzimidazole compound |
| 02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/25/2009 | CN100463907C Preparing method of 1-(5-nitro-1H-indole-2-carbonyl)-4-{3-[(1-methylethyl)amino]-2-pyridine} |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495022 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 02/24/2009 | US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease |
| 02/24/2009 | US7495016 inhibiting HIV replication in a cell; inhibiting reverse transcriptase |
| 02/24/2009 | US7495014 Gyrase inhibitors and uses thereof |
| 02/24/2009 | US7495013 Chemokine receptor modulators or Histamine H1 antagonists; autoimmune, inflammatory, proliferative or hyperproliferative diseases, or immune diseases; Methyl 4-[[4-(2,4dichloro-3-methylphenoxy)-1-piperidinyl]methyl]-alpha-(phenylmethyl)-1-piperidineacetate for example |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/24/2009 | US7495000 Variolin derivatives and their use as antitumor agents |
| 02/24/2009 | US7494997 excellent BCR-ABL tyrosine kinase inhibitory activity; to treat leukemias; 3-bromo-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl}benzamide; compounds with cell growth inhibitory effect |
| 02/24/2009 | US7494996 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/19/2009 | WO2009023844A2 3' substituted compounds having 5-ht6 receptor affinity |
| 02/19/2009 | WO2009023752A1 Adrenergic compounds |
| 02/19/2009 | WO2009023677A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 02/19/2009 | WO2009023664A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | WO2009023539A2 Tetrahydropyridine carboxamide derivatives as trpvl antagonists |
| 02/19/2009 | WO2009022727A1 Rare earth complex and luminescent material using the same |
| 02/19/2009 | WO2009022600A1 Process for production of hydrazine compound, intermediate for production of hydrazine compound, and process for production of the intermediate |
| 02/19/2009 | WO2009022171A1 Pyridinyiioxy pyridines as alk5 inhibitors |